스마트 흡입기 : 세계 시장

The global market for smart inhalers was valued at $5.9 billion in 2025 and is estimated to reach $12.1 billion by 2030, at a compound annual growth rate (CAGR) of 15.4% from 2025 through 2030.

The North American market for smart inhalers was valued at $2 billion in 2025 and is estimated to reach $4.4 billion by 2030, at a CAGR of 17.3% from 2025 through 2030.

The Asia-Pacific market for smart inhalers was valued at $1.2 billion in 2025 and is estimated to reach $2.7 billion by 2030, at a CAGR of 18.3% from 2025 through 2030.

Report Scope

The report provides detailed information on the global smart inhalers market. It analyzes market trends using 2024 data, provides estimates for 2025, and projects a compound annual growth rate (CAGR) from 2025 through 2030 for the global smart inhalers market. The report highlights current and future market potential and provides an in-depth discussion of the competitive landscape. It also examines regulatory scenarios, key market drivers, restraints, and emerging opportunities. The report also includes market share analysis for leading companies operating in the smart inhalers ecosystem.

In this report, the smart inhalers market is segmented by product type, disease indication, and distribution channel.

By region, the market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America. The regional segment covered a detailed analysis of the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. Market data is provided for 2024, the base year, with forecasts for 2025 and a 2030 forecast value.

The report aims to:

• Analyze key product types and technology platforms within the smart inhalers market.
• Evaluate the global market size and detailed segmentation.
• Examine major market drivers, restraints, and opportunities.
• Provide comprehensive market forecasts through 2030.
• Assess market share distribution, competitive dynamics, and industry structure.
• Identify potential long-term impacts of digital health, regulatory evolution, and technological innovation on the smart inhalers market.

Report Includes

• 101 data tables and 45 additional tables
• In-depth analysis of the global market for smart inhalers and related technologies
• Analyses of the global market trends, with historic revenue data from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue forecasts, accompanied by a corresponding market share analysis based on based on product type, disease indication, distribution channel, and region
• Facts and figures pertaining to the market dynamics, technological advances, regulations, prospects, and the impact of macroeconomic variables
• Coverage of evolving technologies and reimbursement trends and practices
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Review of key granted and published patents
• Analysis of the industry structure, including companies' shares and global rankings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
• Company profiles of major players within the industry, including Aptar.com, AstraZeneca, GSK plc, Novartis AG, CHIESI Farmaceutici S.p.A., Adherium, and Boehringer Ingelheim International GmbH

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Current and Future Market Overview
• Macroeconomic Factor Analysis
• Impact of U.S. Tariffs on the Pharmaceutical Industry
• Impact of the Ukraine-Russia War on the Smart Inhalers Industry
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Burden of Asthma and Chronic Respiratory Diseases
• High Prevalence of Medication Nonadherence
• Regulatory and Digital Health Enablement
• Market Restraints
• High Costs and Limited Reimbursement Coverage
• Limited Long-Term Clinical and Economic Evidence
• Patient Engagement Gaps and Digital Divide
• Market Opportunities
• Advanced Sensing and AI-Enabled Personalized Care
• Strategic Pharma Partnerships and Data-Driven Labeling

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologies and Patent Analysis

• Overview
• Advanced Sensing Technologies
• Artificial Intelligence (AI) and Machine Learning (ML)
• Digital Biomarkers and Disease Phenotyping
• Edge Computing and Federated Learning
• Power Management, Miniaturization, and Hardware Innovation
• Adaptive Therapy and Closed-Loop Concepts
• Clinical Evidence and Real-World Examples
• Patent Analysis
• Patents, by Year
• Patents, by Jurisdiction
• Patents, by Leading Inventor
• Key Takeaways

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Global Market for Smart Inhalers, by Product Type
• Key Takeaways
• MDI-Based Smart Inhalers
• DPI-Based Smart Inhalers
• Other Product Types
• Global Smart Inhalers Market, by Disease Indication
• Key Takeaways
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Disease Indications
• Global Smart Inhalers Market, by Distribution Channel
• Key Takeaways
• Retail Pharmacies
• Online and Direct-to-Consumer Channel
• Hospital Pharmacies
• Geographic Breakdown
• Global Market for Smart Inhalers by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Company Share Analysis

Chapter 8 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• ADHERIUM
• AMIKO DIGITAL HEALTH LTD.
• APTAR.COM
• ASTRAZENECA
• BIOCORP
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• CHIESI FARMACEUTICI S.P.A.
• COGNITA LABS LLC.
• FINDAIR SP. Z O.O
• GSK PLC
• NOVARTIS AG
• NUVOAIR MEDICAL
• PERSONAL AIR QUALITY SYSTEMS PVT. LTD.
• PRESSPART VERWALTUNGS GMBH
• SMART RESPIRATORY PRODUCTS LTD.
• Emerging Players in the Smart Inhalers Market